Breast – Invasive breast cancer of no special type (NST) with strong nuclear FOXA1 positivity of all tumor cells.
Breast – Invasive lobular breast cancer with strong nuclear FOXA1 immunostaining of tumor cells.
Colon – Colorectal adenocarcinoma with faint nuclear FOXA1 staining of a small subset of tumor cells.
Colon – Colorectal adenocarcinoma with strong FOXA1 immunostaining of all tumor cells.
Colon – Colorectal adenocarcinoma with strong nuclear FOXA1 staining of 90_ tumor cells while one gland remains completely FOXA1 negative.
Kidney – FOXA1 negative clear cell carcinoma
Kidney – FOXA1 negative oncocytoma.
Kidney – FOXA1 negative papillary renal cell carcinoma.
Lung – Adenocarcinoma with strong nuclear FOXA1 immunostaining of tumor cells.
Lung – FOXA1 negative malignant mesothelioma (epitheloid).
Lung – Squamous cell carcinoma with moderate to strong nuclear FOXA1 staining of tumor cells.
Oral cavity – FOXA1 negative squamous cell carcinoma.
Ovary – FOXA1 negative clear cell carcinoma.
Ovary – FOXA1 negative endometroid carcinoma.
Ovary – FOXA1 negative serous high-grade carcinoma.
Pharynx – Squamous cell carcinoma with strong nuclear FOXA1 staining of tumor cells.
Prostate – Adenocarcinoma (Gleason 3+3=6) with strong, predominantly nuclear FOXA1 staining of tumor cells.
Prostate – Adenocarcinoma (Gleason 4+4=8) with strong nuclear FOXA1 staining of all tumor cells.
Testis – FOXA1 negative seminoma.
Thyroid – FOXA1 negative papillary carcinoma.
Urinary bladder – Muscle-invasive urothelial carcinoma with strong nuclear FOXA1 positivity of all tumor cells.
Urinary bladder – Non-invasive urothelial carcinoma (low grade, pTaG2) with strong nuclear FOXA1 staining of tumor cells.